Cis-Urocanic acid stimulates primary human keratinocytes independently of serotonin or platelet-activating factor receptors

Journal of Investigative Dermatology

Volumn 129, Issue 11, 2009, Pages 2567-2573

  Kaneko, Kazuyo ^a   Travers, Jeffrey B ^b   Matsui, Mary S ^c   Young, Antony R ^a   Norval, Mary ^d   Walker, Susan L ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b INDIANA UNIVERSITY   (United States)

^c Estee Lauder Inc   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INTERLEUKIN 6; PROSTAGLANDIN E2; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UROCANIC ACID;

ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG INHIBITION; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; KERATINOCYTE; MEDIATOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 70350057610     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.129     Document Type: Article

References (45)

1. Alappatt C, Johnson CA, Clay KL, Travers JB (2000) Acute keratinocyte damage stimulates platelet-activating factor production. Arch Dermatol Res 292:256-259
2. Albert DH, Magoc TJ, Tapang P, Luo G, Morgan DW, Curtin M et al. (1997) Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist. Eur J Pharmacol 325:69-80
3. Audinot V, Lochon S, Newman-Tancredi A, Lavielle G, Millan MJ (1997) Binding profile of the novel 5-HT1B/1D receptor antagonist, [3H]GRa125,743, in guinea-pig brain: a comparison with [3H]5-carboxamidotryptamine. Eur J Pharmacol 327:247-256
4. Bailey SR, Andrews MJ, Elliott J, Cunningham FM (2000) Differential activation of platelets from normal and allergic ponies by PAF and ADP. Inflamm Res 49:224-230
5. Barber LA, Spandau DF, Rathman SC, Murphy RC, Johnson CA, Kelley SW et al. (1998) Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem 273:18891-18897
6. Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (1993) Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 268:23422-23426
7. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152
8. Bayer H, Muller T, Myrtek D, Sorichter S, Ziegenhagen M, Norgauer J et al. (2007) Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol 36:85-93
9. Calignano A, Cirino G, Meli R, Persico P (1988) Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. J Pharmacol Methods 19:89-91
10. Chesney CM, Pifer DD, Byers LW, Muirhead EE (1982) Effect of platelet-activating factor (PAF) on human platelets. Blood 59:582-585
11. Cloez-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM (2003) Differential effect of serotonin on cytokine production in lipopolysac-charide- stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 15: 233-240
12. Durk T, Panther E, Muller T, Sorichter S, Ferrari D, Pizzirani C et al. (2005) 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int Immunol 17:599-606
13. Fisher MS, Kripke ML (1977) Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogen-esis. Proc Natl Acad Sci USA 74:1688-1692
14. Gibbs NK, Tye J, Norval M (2008) Recent advances in urocanic acid photochemistry, photobiology and photoimmunology. Photochem Photobiol Sci 7:655-667
15. Idzko M, Panther E, Stratz C, Muller T, Bayer H, Zissel G et al. (2004) The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 172:6011-6019
16. Jackson M, Thomson KE, Laker R, Norval M, Hunter JA, McKenzie RC (1996) Lack of induction of IL-10 expression in human keratinocytes. J Invest Dermatol 106:1329-1331
17. Kaneko K, Smetana-Just U, Matsui M, Young AR, John S, Norval M et al. (2008) cis-Urocanic acid initiates gene transcription in primary human keratinocytes. J Immunol 181:217-224
18. Kelly DA, Young AR, McGregor JM, Seed PT, Potten CS, Walker SL (2000) Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 191:561-566
19. Kravis TC, Henson PM (1975) IgE-induced release of a platelet-activating factor from rabbit lung. J Immunol 115:1677-1681
20. Kurimoto I, Streilein JW (1992) cis-Urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. J Immunol 148:3072-3078
21. Martin LL, Sanders-Bush E (1982) Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn Schmiede-bergs Arch Pharmacol 321:165-170
22. Matsumura Y, Byrne SN, Nghiem DX, Miyahara Y, Ullrich SE (2006) A role for inflammatory mediators in the induction of immunoregulatory B cells. J Immunol 177:4810-4817
23. Mencia-Huerta JM, Benveniste J (1979) Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol 9:409-415
24. Nilsson G, Metcalfe DD, Taub DD (2000) Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology 99:314-319
25. Nordlind K, Azmitia EC, Slominski A (2008) The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol 17:301-311
26. Norval M (2006) The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog Biophys Mol Biol 92:108-118
27. Norval M, Simpson TJ, Bardshiri E, Howie SE (1989) Urocanic acid analogues and the suppression of the delayed type hypersensitivity response to herpes simplex virus. Photochem Photobiol 49:633-639
28. Pei Y, Barber LA, Murphy RC, Johnson CA, Kelley SW, Dy LC et al. (1998) Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 161:1954-1961
29. Pellon MI, Fernandez-Gallardo S, Gijon MA, Garcia MC, Liu FT, Sanchez CM (1993) Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions. Immunopharmacology 26:73-82
30. Reeve VE, Tyrrell RM, Allanson M, Domanski D, Blyth L (2009) The role of interleukin-6 in UVA protection against UVB-induced immunosuppres-sion. J Invest Dermatol 129:1539-1546
31. Rundhaug JE, Fischer SM (2008) Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem Photobiol 84:322-329
32. Shreedhar V, Giese T, Sung VW, Ullrich SE (1998) A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 160:3783-3789
33. Simon HU, Tsao PW, Siminovitch KA, Mills GB, Blaser K (1994) Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J Immunol 153:364-377
34. Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, Wortsman J (2003) Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol 196:144-153
35. Sreevidya CS, Khaskhely NM, Fukunaga A, Khaskina P, Ullrich SE (2008) Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists. Cancer Res 68:3978-3984
36. Steenvoorden DP, Beijersbergen van HG (1999) Protection against UV-induced systemic immunosuppression in mice by a single topical application of the antioxidant vitamins C and E. Int J Radiat Biol 75:747-755
37. Termorshuizen F, Garssen J, Norval M, Koulu L, Laihia J, Leino L et al. (2002) A review of studies on the effects of ultraviolet irradiation on the resistance to infections: evidence from rodent infection models and verification by experimental and observational human studies. Int Immunopharmacol 2:263-275
38. Teunissen MBM, Koomen CW, Jansen J, De Waal Malefyt R, Schmitt E, Van Den Wijngaard RMJG et al. (1997) In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL-10 mRNA and protein. Clin Exp Immunol 107:213-223
39. Travers JB, Huff JC, Rola-Pleszczynski M, Gelfand EW, Morelli JG, Murphy RC (1995) Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol 105:816-823
40. Travers JB, Leung DY, Johnson C, Schlievert P, Marques M, Cosgrove J et al. (2003) Augmentation of staphylococcal alpha-toxin signaling by the epidermal platelet-activating factor receptor. J Invest Dermatol 120:789-794
41. Walterscheid JP, Nghiem DX, Kazimi N, Nutt LK, McConkey DJ, Norval M et al. (2006) Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci USA 103:17420-17425
42. Walterscheid JP, Ullrich SE, Nghiem DX (2002) Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 195:171-179
43. Woodward EA, Prele CM, Finlay-Jones JJ, Hart PH (2006) The receptor for cis-urocanic acid remains elusive. J Invest Dermatol 126:1191-1193
44. Yang GB, Qiu CL, Zhao H, Liu Q, Shao Y (2006) Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques. J Neuroimmunol 178:24-29
45. Zhang Q, Yao Y, Konger RL, Sinn AL, Cai S, Pollok KE et al. (2008) UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system. J Invest Dermatol 128:1780-1787